Publicaciones en colaboración con investigadores/as de Hospital de Cruces (9)

2015

  1. Metabolomics in non-arteritic anterior ischemic optic neuropathy patients by liquid chromatography–quadrupole time-of-flight mass spectrometry

    Metabolomics, Vol. 11, Núm. 2, pp. 468-476

2013

  1. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat

    Experimental Eye Research, Vol. 110, pp. 55-58

2012

  1. Dacryocystitis: Systematic approach to diagnosis and therapy

    Current Infectious Disease Reports, Vol. 14, Núm. 2, pp. 137-146

  2. Effect of synthetic cannabinoid CB1 agonist (WIN 55212-2) and antagonist (AM 251) on intraocular pressure in rats

    Glaucoma: Etiology, Pathogenesis and Treatments (Nova Science Publishers, Inc.), pp. 147-156

2011

  1. Current trends in glaucoma: What's about neuroprotection?

    Advances in Medicine and Biology (Nova Science Publishers, Inc.), pp. 149-174

  2. Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model

    Clinical and Experimental Ophthalmology, Vol. 39, Núm. 8, pp. 799-807

  3. Review of tumours of the paranasal sinuses based on 14 cases

    Brain Cancer, Tumor Targeting and Cervical Cancer (Nova Science Publishers, Inc.), pp. 261-276

2010

  1. Optic neuropathy in methylmalonic acidemia: The role of neuroprotection

    Journal of Inherited Metabolic Disease, Vol. 33, Núm. SUPPL. 3

  2. Study on the effectiveness of antibiotic prophylaxis in external dacryocystorhinostomy: A review of 697 cases

    Ophthalmic Plastic and Reconstructive Surgery, Vol. 26, Núm. 6, pp. 467-472